Clinical Outcomes Of A Multicenter Study Following Implantation Of An Isofocal Optic Iol With Double C-Loop Haptics
Published 2026 - 44th Congress of the ESCRS
Reference: POCAT437 | Type: Free paper | DOI: 10.82333/e3g5-0z89
Authors: Dr Romain Mouchel* 1 , Dr Camille Bosc 2
1Centre Ophtalmologique Kleber,Lyon,France, 2Institut Ophtalmologique de l'Ouest Jules Verne,Nantes,France
Purpose
To evaluate the clinical outcomes of patients implanted with an isofocal intraocular lens (IOL) featuring a double C-loop haptic following cataract surgery.
Setting
This was a prospective multicenter study including 108 eyes of 54 patients implanted with the Isopure Serenity intraocular lens (Beaver-Visitec International, Inc.)
Methods
At least 3 months after surgery, the following parameters were analyzed: refraction, defocus curve, monocular uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), and distance-corrected intermediate visual acuity (DCIVA) at 80 cm and 66 cm, as well as uncorrected near visual acuity (UNVA) and distance-corrected near visual acuity (DCNVA) at 40 cm.
Results
79.63% and 98.15% of eyes were within ±0.50 D and ±1.00 D of the target spherical equivalent, respectively.
68.41% and 98.15% of eyes achieved a UDVA and CDVA of 20/20 or better, respectively.
77.14% and 39.39% of eyes achieved a UIVA of 20/32 or better at 80 cm and 66 cm, respectively, while 90% and 72.73% achieved a DCIVA of 20/40 or better at 80 cm and 66 cm, respectively.
The defocus curve showed a depth of focus of 1.75 D.
Conclusions
Patients implanted with the new Isopure Serenity IOL with double C-loop haptics demonstrated excellent distance visual performance, functional intermediate vision, and accurate refractive outcomes.